At lower concentrations of 1 and 5 μM, mifepristone was found to be less effective at blocking either the levels of phosphorylated Akt or phospho p44/42 MAPK in the oral cancer cell lines and accordingly a decrease in cell migration was not observed in scratch or scatter assays. Here, AKT1 is linked to lip and oral cavity carcinoma.